CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows From Operating Activities:
Net income	$ 54,120	$ 51,971
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Discount accretion and premium amortization of financial instruments, net	(4,511)	(7,010)
Amortization of guaranteed loan financing, deferred financing costs, and intangible assets	16,093	17,864
Provision for loan losses	2,559	571
Charge off of real estate acquired in settlement of loans	824	1,236
Change in repair and denial reserve	221	(161)
Net settlement of derivative instruments	(4,068)	4,094
Purchase of loans, held for sale, at fair value	(4,458)	(17,481)
Origination of loans, held for sale, at fair value	(1,889,835)	(1,901,321)
Proceeds from disposition and principal payments of loans, held for sale, at fair value	1,859,478	2,056,323
Equity in net income of unconsolidated joint ventures, net of distributions	(5,687)	1,048
Gain on sale of mortgages held for sale included in Residential mortgage banking activities	(41,314)	(28,590)
Gain on derivatives included in Residential mortgage banking activities	(2,998)	(478)
Creation of servicing rights, net of payoffs	(12,621)	(11,910)
Gain on bargain purchase	(30,728)
Net realized gains on financial instruments and real estate owned	(20,914)	(27,796)
Net unrealized losses (gains) on financial instruments	21,799	(15,964)
Net changes in operating assets and liabilities
Assets of consolidated VIEs (excluding loans, net), accrued interest and due from servicers	(3,188)	157
Receivable from third parties	8,183	5,227
Other assets	(17,185)	1,961
Accounts payable and other accrued liabilities	9,360	5,462
Net cash (used in) provided by operating activities	(64,870)	135,203
Cash Flow From Investing Activities:
Origination of loans	(918,805)	(695,470)
Purchase of loans	(569,254)	(360,859)
Purchase of mortgage backed securities, at fair value	(9,593)	(67,338)
Purchase of real estate	(117)	(1,570)
Funding of unconsolidated joint venture	(14,726)
Purchase of servicing rights	(894)	(362)
Proceeds on unconsolidated joint venture in excess of earnings recognized	6,807	13,407
Payment of liability under participation agreements, net of proceeds received		(180)
Proceeds from disposition and principal payment of loans	550,152	621,039
Proceeds from sale and principal payment of mortgage backed securities, at fair value	9,737	22,295
Proceeds from sale of real estate	15,626	1,558
Cash acquired in connection with the ORM Merger	10,822
Net cash (used in) investing activities	(920,245)	(467,480)
Cash Flows From Financing Activities:
Proceeds from secured borrowings	3,956,325	2,836,690
Proceeds from issuance of securitized debt obligations of consolidated VIEs	879,585	390,851
Proceeds from senior secured note offering		41,328
Proceeds from corporate debt	57,500	50,000
Payment of contingent consideration	(1,207)	(8,967)
Payment of secured borrowings	(3,486,916)	(2,650,925)
Payment of securitized debt obligations of consolidated VIEs	(315,474)	(234,816)
Payment of guaranteed loan financing	(30,165)	(55,597)
Payment of promissory note	(1,199)	(744)
Payment of deferred financing costs	(18,127)	(13,944)
Payment of offering costs	(75)	(10)
Contributions, net	70	94
Equity issuance		86
Dividend payments	(45,034)	(37,971)
Net cash provided by financing activities	995,283	316,075
Net increase (decrease) in cash, cash equivalents, and restricted cash	10,168	(16,202)
Cash, cash equivalents, and restricted cash at beginning of period	94,970	90,954
Cash, cash equivalents, and restricted cash at end of period	105,138	74,752
Supplemental disclosure of operating cash flow
Cash paid for interest	94,841	70,259
Cash (received) paid for income taxes	(2,609)	1,058
Stock-based compensation	1,126	367
Supplemental disclosure of non-cash investing activities
Loans transferred from Loans, held for sale, at fair value to Loans, net	750	$ 898
Deconsolidation of assets in securitization trusts	$ 177,815
Supplemental disclosure of non-cash financing activities
Shares issued pursuant to ORM merger transaction (in shares)	12,223,552
Deconsolidation of borrowings in securitization trusts	$ 177,815
Incentive shares issued to investment manager pursuant to management agreement	233	338
Cash and restricted cash reconciliation
Cash and cash equivalents	$ 52,727	$ 47,845
Restricted cash	45,303	18,864
Cash, cash equivalents and restricted cash in Assets of consolidated VIEs	7,108	8,043
Cash, cash equivalents, and restricted cash at end of period	$ 105,138	$ 74,752